|Day Low/High||7.58 / 7.86|
|52 Wk Low/High||2.65 / 13.01|
It may just be a matter of time before the green chokes on the pestilence and the stock market stars don't even matter.
Here we look at the benefits of putting down small cash in buy/write strategies for Coty and Vera Bradley.
I just saw that Sky News is reporting that KKR may be lining up to make an $8 billion bid on Coty's hair care business, that includes Wella, Clairol and Good Hair Day. If true, it's a potentially interesting fit given that KKR has been linked to the...
More is needed than recent positive fundamental news and a bullish price gap.
With competition from the likes of Sephora and slow revenue growth, ULTA seems to be losing its shine, but here's how to play it.
Disney, Qualcomm and Square are among 75 key reports we are watching.
Upgrades Dova Pharmaceuticals upgraded to Outperform from In-line at Evercore ISI Meridian Bancorp upgraded to Overweight from Neutral at Piper Jaffray; price target raised to $20 Landstar System upgraded to Mkt Perform from Underperform at Raymo...
The change is meant to protect against volatility 'in light of the current trading environment'.
Insider buying by corporate officers should be taken as optimistic visions of the future prospects of their companies and their stock prices.
The outlook for Q1 is gloomy, with a triple threat of headwinds on the horizon.
I see a lot of winners here because of hindsight.
These eight S&P 500 stocks have some of the worst returns year-to-date and represent a diverse roster of promising bounce candidates.
Barring unexpected bad news there appears to be no reason that Coty won't jump to at least $12 or $13 by next June.
John Butters and his FactSet team noted individual companies that have seen the largest changes in third-quarter earnings forecasts by sector.
The free market is going to take back control of interest rates.
The fragrance market is booming at all price-points. We got an inside look at the luxury end, where bottles can cost up to $1,000.
Procter & Gamble has been making all sorts of news for the past month, but not because of a host of cool new products. No, because of an ugly board battle with activist investor Nelston Peltz. TheStreet talks exclusively with P&G CEO David Taylor about the company and Peltz.